Home Depot realigns leadership to speed innovation, target bigger share of USD 1.2 trillion marketPUBT·57 minutes agoHD-1.45%
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For VitiligoSimplywall·1 day ago, 06:30 AMABBV-2.24%
UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·15 hours agoUNH+0.21%UNHG+0.40%
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | ABBV Stock NewsStockTitan·1 day ago, 06:00 PMABBV-2.24%
AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full AnalysisTradingKey·2 days ago, 10:18 AMABBV-2.24%
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo | ABBV Stock NewsStockTitan·1 day ago, 06:00 PMABBV-2.24%
Conduent Wins UnitedHealthcare and Optum 2026 Global Innovation Challenge for its Personalized Agentic AI Navigator | CNDT Stock NewsStockTitan·16 hours agoCNDT-3.07%UNH+0.21%
Merck & Co., Inc. $MRK Shares Sold by Redwood Grove Capital LLCMarket Beat·1 day ago, 04:52 AMMRK-0.44%
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose VialsPR Newswire·2 days ago, 01:32 PMMRK-0.44%
A New Data Privacy Class-Action Lawsuit Sends Home Depot Stock (NYSE:HD) SlidingTip Ranks·5 hours agoHD-1.45%
Alignment Healthcare (ALHC) Reports Earnings Tomorrow: What To ExpectStock Story·1 day ago, 10:13 PMCNC-1.59%UNH+0.21%
Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreakbenzinga_article·8 hours agoMRK-0.44%
